These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 17635379)

  • 1. Esophageal Hypervigilance and Visceral Anxiety Are Contributors to Symptom Severity Among Patients Evaluated With High-Resolution Esophageal Manometry.
    Carlson DA; Gyawali CP; Roman S; Vela M; Taft TH; Crowell MD; Ravi K; Triggs JR; Quader F; Prescott J; Lin FTJ; Mion F; Biasutto D; Keefer L; Kahrilas PJ; Pandolfino JE
    Am J Gastroenterol; 2020 Mar; 115(3):367-375. PubMed ID: 31990697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastroesophageal reflux disease, functional dyspepsia and irritable bowel syndrome: common overlapping gastrointestinal disorders.
    de Bortoli N; Tolone S; Frazzoni M; Martinucci I; Sgherri G; Albano E; Ceccarelli L; Stasi C; Bellini M; Savarino V; Savarino EV; Marchi S
    Ann Gastroenterol; 2018; 31(6):639-648. PubMed ID: 30386113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing a diagnostic understanding of GERD phenotypes through the analysis of levels of mucosal injury, immune activation, and psychological comorbidity.
    Zhong C; Liu K; Wang K; Liu H; Su H; Wu J; Duan L
    Dis Esophagus; 2018 Oct; 31(10):. PubMed ID: 29757356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychosocial Distress and Quality of Life Impairment Are Associated With Symptom Severity in PPI Non-Responders With Normal Impedance-pH Profiles.
    Yadlapati R; Tye M; Keefer L; Kahrilas PJ; Pandolfino JE
    Am J Gastroenterol; 2018 Jan; 113(1):31-38. PubMed ID: 28895583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychological Comorbidity and Chronic Heartburn: Which Is the Chicken and Which Is the Egg?
    Fass R; Fass SS
    Dig Dis Sci; 2017 Apr; 62(4):823-825. PubMed ID: 28205110
    [No Abstract]   [Full Text] [Related]  

  • 6. Dexlansoprazole - a new-generation proton pump inhibitor.
    Skrzydło-Radomańska B; Radwan P
    Prz Gastroenterol; 2015; 10(4):191-6. PubMed ID: 26759624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients with refractory reflux symptoms: What do they have and how should they be managed?
    Kahrilas PJ; Keefer L; Pandolfino JE
    Neurogastroenterol Motil; 2015 Sep; 27(9):1195-201. PubMed ID: 26303047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New Approaches to Management of PPI-Refractory Gastroesophageal Reflux Disease.
    Ates F; Vaezi MF
    Curr Treat Options Gastroenterol; 2014 Mar; 12(1):18-33. PubMed ID: 24430334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton pump inhibitor resistance, the real challenge in gastro-esophageal reflux disease.
    Cicala M; Emerenziani S; Guarino MP; Ribolsi M
    World J Gastroenterol; 2013 Oct; 19(39):6529-35. PubMed ID: 24151377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overlap of functional heartburn and gastroesophageal reflux disease with irritable bowel syndrome.
    de Bortoli N; Martinucci I; Bellini M; Savarino E; Savarino V; Blandizzi C; Marchi S
    World J Gastroenterol; 2013 Sep; 19(35):5787-97. PubMed ID: 24124323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Many patients continue using proton pump inhibitors after negative results from tests for reflux disease.
    Gawron AJ; Rothe J; Fought AJ; Fareeduddin A; Toto E; Boris L; Kahrilas PJ; Pandolfino JE
    Clin Gastroenterol Hepatol; 2012 Jun; 10(6):620-5; quiz e57. PubMed ID: 22366177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The hypersensitive esophagus: pathophysiology, evaluation, and treatment options.
    Remes-Troche JM
    Curr Gastroenterol Rep; 2010 Oct; 12(5):417-26. PubMed ID: 20669058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient and physician satisfaction with proton pump inhibitors (PPIs): are there opportunities for improvement?
    Chey WD; Mody RR; Izat E
    Dig Dis Sci; 2010 Dec; 55(12):3415-22. PubMed ID: 20397047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overlapping gastroesophageal reflux disease and irritable bowel syndrome: increased dysfunctional symptoms.
    Yarandi SS; Nasseri-Moghaddam S; Mostajabi P; Malekzadeh R
    World J Gastroenterol; 2010 Mar; 16(10):1232-8. PubMed ID: 20222167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastroesophageal reflux disease (GERD) and irritable bowel syndrome (IBS)--is it one disease or an overlap of two disorders?
    Gasiorowska A; Poh CH; Fass R
    Dig Dis Sci; 2009 Sep; 54(9):1829-34. PubMed ID: 19082721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refractory GERD: what is it?
    Fass R; Gasiorowska A
    Curr Gastroenterol Rep; 2008 Jun; 10(3):252-7. PubMed ID: 18625135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oesophageal hypersensitivity is associated with features of psychiatric disorders and the irritable bowel syndrome.
    Rubenstein JH; Nojkov B; Korsnes S; Adlis SA; Shaw MJ; Weinman B; Inadomi JM; Saad R; Chey WD
    Aliment Pharmacol Ther; 2007 Aug; 26(3):443-52. PubMed ID: 17635379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive association between gastro-oesophageal reflux disease and irritable bowel syndrome in a Chinese population.
    Cheung TK; Lam KF; Hu WH; Lam CL; Wong WM; Hui WM; Lai KC; Lam SK; Wong BC
    Aliment Pharmacol Ther; 2007 May; 25(9):1099-104. PubMed ID: 17439511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypervigilance in irritable bowel syndrome compared with organic gastrointestinal disease.
    Posserud I; Svedlund J; Wallin J; Simrén M
    J Psychosom Res; 2009 May; 66(5):399-405. PubMed ID: 19379956
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.